Vaccination

France recommends AstraZeneca jab for over-55s only

France's health regulator recommended Friday that only people aged 55 and over be administered AstraZeneca's COVID-19 vaccine due to reports of blood clots, while giving the green light to resume its use after a brief suspension.

Vaccination

Europe pause of AstraZeneca sends ripple of doubt elsewhere

The suspension of the AstraZeneca vaccine in several European countries over the past week could fuel skepticism about the shot far beyond their shores, potentially threatening the rollout of a vaccine that is key to the ...

Diseases, Conditions, Syndromes

COVID-19: Bioethical issues raised by the pandemic

Mark Aulisio, the Susan E. Watson Professor and chair of the Department of Bioethics at Case Western Reserve University School of Medicine, weighed in on bioethical issues that have arisen as a result of the COVID-19 pandemic ...

Diseases, Conditions, Syndromes

BioNTech says can make mutation-beating vaccine in six weeks

The co-founder of BioNTech said Tuesday it was "highly likely" that its vaccine against the coronavirus works against the mutated strain detected in Britain, but it could also adapt the vaccine if necessary in six weeks.

page 4 from 6